Hopp til innhold
NHI.no
Annonse

Bakteriell vaginose: Prognose

Innhold i artikkelen

Tilbakefall er svært vanlig både hos de som har fått behandling og hos de som er blitt bra av seg selv. Man blir ofte bra uten behandling, og det anses fornuftig å avvente utviklingen dersom plagene ikke er for uttalte. Når plagene er for uttalte, for eksempel på grunn av lukt, kløe eller ubehag, gis en kur. Behandlingen har som regel svært rask virkning, men gjentatte kurer kan bli nødvendig. 

Annonse

Bakteriell vaginose er funnet å ha en sammenheng med økt risiko for seksuelt overførte infeksjoner som klamydiainfeksjon, gonoré, genital herpesvirus infeksjon og HPV infeksjon. 

Vil du vite mer

Dette dokumentet er basert på det profesjonelle dokumentet Bakteriell vaginose . Referanselisten for dette dokumentet vises nedenfor

  1. Helsedirektoratet (2021). Nasjonal faglig retningslinje for antibiotika i primærhelsetjenesten nettdokument. Oslo: Helsedirektoratet (sist faglig oppdatert 16. november 2021, Siden lest 7. januar 2025). www.helsedirektoratet.no
  2. Kairys N, Carlson K, Garg M. Bacterial Vaginosis. 2024 May 6. In: StatPearls Internet. Treasure Island (FL): StatPearls Publishing; 2022 Jan–. PMID: 29083654. Accessed 2025 Jan 7 www.ncbi.nlm.nih.gov
  3. Muzny CA, Sobel JD. Bacterial Vaginosis - Time to Treat Male Partners. N Engl J Med. 2025 Mar 6;392(10):1026-1027. PMID: 40043241. PubMed
  4. Paavonen J, Brunham RC. Bacterial Vaginosis and Desquamative Inflammatory Vaginitis. N Engl J Med 2018; 379: 2246-54. PMID: 30575452 PubMed
  5. Vodstrcil LA, Hocking JS, Law M, et al. Hormonal contraception is associated with a reduced risk of bacterial vaginosis: a systematic review and meta-analysis. PLoS One. 2013;8 :e73055. PMID: 24023807 PubMed
  6. Peebles K, Velloza J, Balkus JE et al. High Global Burden and Costs of Bacterial Vaginosis: A Systematic Review and Meta-Analysis. Sex Transm Dis. 2019 May;46(5):304-311. PMID: 30624309 PubMed
  7. Vodstrcil LA, Plummer EL, Fairley CK, et al. Male-Partner Treatment to Prevent Recurrence of Bacterial Vaginosis. N Engl J Med. 2025 Mar 6;392(10):947-957. PMID: 40043236. PubMed
  8. Achilles SL, Austin MN, Meyn LA, Mhlanga F, Chirenje ZM, Hillier SL. Impact of contraceptive initiation on vaginal microbiota. Am J Obstet Gynecol. 2018 Jun;218(6):622.e1-622.e10. doi: 10.1016/j.ajog.2018.02.017. Erratum in: Am J Obstet Gynecol. 2021 Oct;225(4):434. PMID: 29505773. PubMed
  9. Amsel R, Totten PA, Spiegel CA, Chen KC, Eschenbach D, Holmes KK. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med 1983; 74:14-22. PubMed
  10. Vieira-Baptista P, Silva AR, Costa M et al. Diagnosis of bacterial vaginosis: Clinical or microscopic? A cross-sectional study. Int J Gynaecol Obstet. 2022 Mar;156(3):552-559. Epub 2021 Jul 12. PMID: 34160078 PubMed
  11. Lowe NK, Neal JL, Ryan-Wenger NA. Accuracy of the clinical diagnosis of vaginitis compared with a DNA probe laboratory standard. Obstet Gynecol 2009; 113: 89-95. PubMed
  12. Nodenes K, Gammelsrud KW, Findal G. Bakteriell vaginose. Veielder i fødselshjelp. Norsk gynekologisk forening. Oslo, 2024 metodebok.no
  13. Brocklehurst P, Gordon A, Heatley E, Milan SJ. Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database of Systematic Reviews 2013, Issue 1. Art. No.: CD000262. DOI: 10.1002/14651858.CD000262.pub4. DOI
  14. Mendling W, Weissenbacher ER, Gerber S, et al. Use of locally delivered dequalinium chloride in the treatment of vaginal infections: a review. Arch Gynecol Obstet 2016; 293: 469-84. pmid:26506926 PubMed
  15. Amaya-Guio J, Viveros-Carreño DA, Sierra-Barrios EM, Martinez-Velasquez MY, Grillo-Ardila CF. Antibiotic treatment for the sexual partners of women with bacterial vaginosis. Cochrane Database of Systematic Reviews 2016, Issue 10. Art. No.: CD011701. DOI: 10.1002/14651858.CD011701.pub2 DOI
  16. Subtil D, Brabant G, Tilloy E et al. Early clindamycin for bacterial vaginosis in pregnancy (PREMEVA): a multicentre, double-blind, randomised controlled trial. Lancet 2018. pmid:30322724 PubMed
  17. Afifirad R, Darb Emamie A, Golmoradi Zadeh R et al. Effects of Pro/Prebiotics Alone over Pro/Prebiotics Combined with Conventional Antibiotic Therapy to Treat Bacterial Vaginosis: A Systematic Review. Int J Clin Pract. 2022 Apr 21;2022:4774783. PMID: 35685517 PubMed
  18. Cohen CR, Wierzbicki MR, French AL et al. Randomized Trial of Lactin-V to Prevent Recurrence of Bacterial Vaginosis. N Engl J Med 2020; 382:1906-1915. PMID: 32402161 PubMed
  19. van de Wijgert J, Verwijs MC. Lactobacilli-containing vaginal probiotics to cure or prevent bacterial or fungal vaginal dysbiosis: a systematic review and recommendations for future trial designs. BJOG. 2020 Jan;127(2):287-299. Epub 2019 Aug 8. PMID: 31299136 PubMed
  20. Larsson PG, Stray-Pedersen B, Ryttig KR, Larsen S. Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study. BMC Womens Health 2008; 8: 3. PubMed
  21. Bradshaw CS, Morton AN, Hocking J, et al. High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. J Infect Dis 2006; 193: 1478. PubMed
  22. Kahwati LC, Clark R, Berkman N et al. Screening for Bacterial Vaginosis in Pregnant Adolescents and Women to Prevent Preterm Delivery: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2020 Apr 7;323(13):1293-1309. PMID: 32259235 PubMed
Annonse
Annonse